|
[Related PubMed/MEDLINE]
Total Number of Papers: 297
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: sIL-6R |
| Long Form |
: soluble IL-6 receptor |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Effect of NMO-IgG on the interleukin-6 cascade in astrocytes via activation of the JAK/STAT3 signaling pathway. |
AQP4, IL-6, NMOSD |
| 2 |
2020 |
Estrogen downregulates gp130 expression in HUVECs by regulating ADAM10 and ADAM17 via the estrogen receptor. |
ADAM10, gp130, HUVECs, IL-6, sgp130 |
| 3 |
2020 |
The ADAM17 protease promotes tobacco smoke carcinogen-induced lung tumorigenesis. |
NNK |
| 4 |
2020 |
Tumour necrosis factor alpha promotes secretion of 14-3-3eta by inducing necroptosis in macrophages. |
IL, MLKL, RA, TNF |
| 5 |
2019 |
A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity. |
CVDs, MR |
| 6 |
2019 |
Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation. |
IL-6, IR, STAT, TGF, UUO |
| 7 |
2019 |
Correlation of magnetic resonance imaging grades with cytokine levels of synovial fluid of patients with temporomandibular joint disorders: a cross-sectional study. |
IL, MRI, NRS, TMJ |
| 8 |
2019 |
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation. |
IL-6TS, U-BIOPRED |
| 9 |
2019 |
IL-6 Trans-signaling Controls Liver Regeneration After Partial Hepatectomy. |
gp130, IL-6 |
| 10 |
2019 |
Inhibition of interleukin-6 trans-signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells. |
HRECs, IL-6 |
| 11 |
2019 |
Interleukin 6 trans-signalling and risk of future cardiovascular events. |
CI, CV, CVE, HR, IL-6 |
| 12 |
2019 |
Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction. |
IL-6, LVEF, sGP, STEMI |
| 13 |
2019 |
The synergistic action of phosphate and interleukin-6 enhances senescence-associated calcification in vascular smooth muscle cells depending on p53. |
ESRD, IL-6, STAT3, VSMCs |
| 14 |
2018 |
Association between allergic and nonallergic rhinitis and obstructive sleep apnea. |
NAR, OSA, SDB |
| 15 |
2018 |
Combination of 4-hydroperoxy cyclophosphamide and methotrexate inhibits IL-6/sIL-6R-induced RANKL expression in fibroblast-like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway. |
4-H-CTX, FLS, IL, MTX, RA, RANKL |
| 16 |
2018 |
Fungal metabolite (+)-terrein suppresses IL-6/sIL-6R-induced CSF1 secretion by inhibiting JAK1 phosphorylation in human gingival fibroblasts. |
CSF1, HGFs, IL-6, JAK1, VEGF |
| 17 |
2018 |
High Glucose-Mediated Cytokine Regulation in Gingival Fibroblasts and THP-1 Macrophage: a Possible Mechanism of Severe Periodontitis with Diabetes. |
CM, CPT, DM, GCF, HG, HGFs, IL, IL-1ra, MMPs, NG, TIMP-1 |
| 18 |
2018 |
Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute andchronic kidney disease. |
AKI, CKD, FGF23, HIL-6, IL-6 |
| 19 |
2018 |
Interleukin-6-mediated trans-signaling inhibits transforming growth factor-beta signaling in trabecular meshwork cells. |
HTM, MLC2, POAG, TGF-beta2 |
| 20 |
2018 |
Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia. |
CIRS, HDRS, IL, MADRS, sIL-1RA, sIL-2R, TBARS, TRD |
| 21 |
2018 |
Lymphatic growth factors are expressed in human gingiva and upregulated in gingival fibroblasts after stimulation. |
ELISA, HGFs, LPS, qRT-PCR, VEGF |
| 22 |
2018 |
Neonatal Inflammatory Markers Are Associated with Childhood B-cell Precursor Acute Lymphoblastic Leukemia. |
ALL, CRP, MCP |
| 23 |
2018 |
Soluble glycoprotein 130 is inversely related to severity of coronary atherosclerosis. |
CAD, IL-6, sgp130 |
| 24 |
2018 |
Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients. |
MSC |
| 25 |
2017 |
A Role for Soluble IL-6 Receptor in Osteoarthritis. |
ADAM, gp130, IL-6, JAK/STAT, MMP-9, NGAL, OA, RA |
| 26 |
2017 |
Beneficial potential of intravenously administered IL-6 in improving outcome after murine experimental stroke. |
IL-6, pMCAO |
| 27 |
2017 |
Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma. |
IL |
| 28 |
2017 |
Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature. |
IL-6, IL-6R, NO |
| 29 |
2017 |
Circulating Soluble IL-6 Receptor Concentration and Visceral Adipocyte Size Are Related to Insulin Resistance in Taiwanese Adults with Morbid Obesity. |
BMI, HOMA-IR, IL, mIL-6R |
| 30 |
2017 |
COPD monocytes demonstrate impaired migratory ability. |
IL-6, NS |
| 31 |
2017 |
IL-6 Trans-Signaling Links Inflammation with Angiogenesis in the Peritoneal Membrane. |
HPMCs, PD, VEGF |
| 32 |
2017 |
Inflammatory Markers and Frailty in Long-Term Care Residents. |
hs-CRP, IL-6, LTC, TNF-alpha |
| 33 |
2017 |
Inhibitory Mechanism of the Outer Membrane Growth of Chronic Subdural Hematomas. |
CSDHs, CSF, IL-6, JAK, PIAS3, SAH, sgp130, SOCS3, STAT |
| 34 |
2017 |
Interleukin-6 and soluble interleukin-6 receptor are elevated in large-vessel vasculitis: a cross-sectional and longitudinal study. |
GCA, NCs, TAK |
| 35 |
2017 |
Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy. |
CHF, CRT, IL-6, sgp130 |
| 36 |
2017 |
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. |
HCs, IL-6, MDD, TNF |
| 37 |
2017 |
Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation. |
ADAM17, IL-6 |
| 38 |
2017 |
Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression. |
--- |
| 39 |
2016 |
Associations Between Delirium and Preoperative Cerebrospinal Fluid C-Reactive Protein, Interleukin-6, and Interleukin-6 Receptor in Individuals with Acute Hip Fracture. |
CRP, CSF, IL-6, IQCODE, IQR |
| 40 |
2016 |
IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3. |
HuMC, MC, SOCS3 |
| 41 |
2016 |
IL-6 stimulates a concentration-dependent increase in MCP-1 in immortalised human brain endothelial cells. |
BBB, IL-6 |
| 42 |
2016 |
IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis. |
--- |
| 43 |
2015 |
Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling. |
CRS, CRSwNP, sgp130, TNF |
| 44 |
2015 |
Allergen-induced IL-6 trans-signaling activates gammadelta T cells to promote type 2 and type 17 airway inflammation. |
HDM, IL-6R |
| 45 |
2015 |
Effects of diet and/or n-3 fatty acid supplementation on components of the interleukin-6 trans-signalling system in elderly men. |
CV, IL-6, Md, n-3 PUFA, sgp130, ts |
| 46 |
2015 |
IL-6 trans-signaling plays important protective roles in acute liver injury induced by acetaminophen in mice. |
AAP, CYP2E1, IL-6, pSTAT3 |
| 47 |
2015 |
Inhibition of interleukin-6 abolishes the promoting effects of pair housing on post-stroke neurogenesis. |
IL-6, NPCs, PH, PH, rIL-6, SVZ, tMCAO |
| 48 |
2015 |
Interleukin-6-mediated functional upregulation of TRPV1 receptors in dorsal root ganglion neurons through the activation of JAK/PI3K signaling pathway: roles in the development of bone cancer pain in a rat model. |
DRG, IL-6, JAK, PI3K, TRPV1 |
| 49 |
2015 |
Role played by interleukin-6 in evoking the exercise pressor reflex in decerebrate rats: effect of femoral artery ligation. |
sGP |
| 50 |
2015 |
Soluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst. |
IAV |
| 51 |
2015 |
STAT1 is Constitutively Activated in the T/C28a2 Immortalized Juvenile Human Chondrocyte Line and Stimulated by IL-6 Plus Soluble IL-6R. |
rhIL-6, STAT1 |
| 52 |
2014 |
Human umbilical cord blood-derived stromal cells: a new resource for the proliferation and apoptosis of myeloma cells. |
Bcl-2, BMSCs, HME, hUCBDSCs, ICAM-1, IL, mIL-6R, MM, NF-kappaB |
| 53 |
2014 |
IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases. |
IL, PBMCs, RA, SFMCs, sJIA, TCZ, TLR |
| 54 |
2014 |
IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent. |
hADSCs, ROR2, siRNA, STAT3, WNT |
| 55 |
2014 |
Induction of an inflammatory and prodegradative phenotype in autologous fibroblast-like synoviocytes by the infrapatellar fat pad from patients with knee osteoarthritis. |
COX-2, FLS, IFP, IL-6, MMPs, mRNA, OA, PGE2, SCAT, sPLA2, TNF-alpha |
| 56 |
2014 |
Interleukin-6 and soluble interleukin-6 receptor levels in posttraumatic stress disorder: associations with lifetime diagnostic status and psychological context. |
IL-6 |
| 57 |
2014 |
Synthetic (+)-terrein suppresses interleukin-6/soluble interleukin-6 receptor induced-secretion of vascular endothelial growth factor in human gingival fibroblasts. |
IL, VEGF |
| 58 |
2014 |
Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? |
sgp130 |
| 59 |
2014 |
The inhibition of N-glycosylation of glycoprotein 130 molecule abolishes STAT3 activation by IL-6 family cytokines in cultured cardiac myocytes. |
ERK, gp130, IL-6, JAKs, LIF, PTP1B, SOCSs, TM |
| 60 |
2013 |
Alternative splicing and proteolytic rupture contribute to the generation of soluble IL-6 receptors (sIL-6R) in rheumatoid arthritis. |
RA |
| 61 |
2013 |
Are pentraxin 3 and transsignaling early markers for immunologic injury severity in polytrauma? A pilot study. |
ISS, OF, PTS, PTX3, TSR |
| 62 |
2013 |
Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR). |
ADAM10, EGFR, IL-6, mTOR, SASP |
| 63 |
2013 |
Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness. |
FPG, IL-6, MetS, PWP, sgp130 |
| 64 |
2013 |
Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma. |
EMDR, IL, Treg |
| 65 |
2013 |
IL-6 is produced by adipose-derived stromal cells and promotes osteogenesis. |
ASCs, ChIP, IL-6, siRNA, TLRs |
| 66 |
2013 |
miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. |
HNC, IL, Spg-miR145, TIC |
| 67 |
2013 |
Psychologic and biologic factors associated with fatigue in patients with persistent radiculopathy. |
IL, NP |
| 68 |
2013 |
Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes. |
FLS, RA, RANKL, STAT3 |
| 69 |
2013 |
Role of interleukin-6, its receptor and soluble gp130 in chronic lung disease of prematurity. |
BALF, CLD, IL-6, sgp130 |
| 70 |
2013 |
Significance of the IL-6 pathway in nasal polyposis in Chinese patients. |
IL-6, NP, p-STAT3, RORC, SOCS3 |
| 71 |
2013 |
Soluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses. |
IL-6, IRF3, Mx, OAS, PKR |
| 72 |
2013 |
The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone. |
--- |
| 73 |
2013 |
Tocilizumab in glucocorticoid-naive large-vessel vasculitis. |
GC, IL-6, LVV, TCZ |
| 74 |
2013 |
Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts. |
IL-6, SSc, TNF, TNFR |
| 75 |
2012 |
An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification. |
MM |
| 76 |
2012 |
Elevated urinary sVCAM-1, IL6, sIL6R and TNFR1 concentrations indicate acute kidney transplant rejection in the first 2 weeks after transplantation. |
IL-6, IL1Ra, sVCAM-1, TNFR1 |
| 77 |
2012 |
Interleukin-6 regulates anti-arthritic effect of methotrexate via reduction of SLC19A1 expression in a mouse arthritis model. |
GPI, IL-6, MTX |
| 78 |
2012 |
Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis. |
ERK, FLS, IL, MAPK, mRNA, RA, STAT3 |
| 79 |
2012 |
Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions. |
IL-6, PD, sGp130 |
| 80 |
2012 |
Osteocyte apoptosis regulates osteoclast precursor adhesion via osteocytic IL-6 secretion and endothelial ICAM-1 expression. |
--- |
| 81 |
2012 |
Pregnancy-associated inflammatory markers are elevated in pregnant women with systemic lupus erythematosus. |
CBA, ELISA, gp130, IL, SLE |
| 82 |
2012 |
Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure. |
CHF, GP, IL, sFas, TNF |
| 83 |
2012 |
Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-alpha blockers. |
IL-6, TA |
| 84 |
2012 |
Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption. |
BMMs, CM, EGFR, LPA, NF, OSCC, rIL-6 |
| 85 |
2012 |
Spinal interleukin-6 is an amplifier of arthritic pain in the rat. |
IL-6 |
| 86 |
2012 |
The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis. |
BMD, GC, IL-6, OPG, RA, sgp130 |
| 87 |
2011 |
Correlations among inflammatory markers in plasma, saliva and oral mucosal transudate in post-menopausal women with past intimate partner violence. |
CRP, IPV, OMT |
| 88 |
2011 |
Dynamic expression of IL-6 trans-signalling molecules in the lungs of preterm baboons undergoing mechanical ventilation. |
IL, MCP-1, sgp130 |
| 89 |
2011 |
Effects of short-term glucocorticoid treatment on changes in cartilage matrix degradation and chondrocyte gene expression induced by mechanical injury and inflammatory cytokines. |
GAG, GR, IL-6, mRNA, TNF-alpha |
| 90 |
2011 |
Increased expression of C-reactive protein gene in inflamed gingival tissues could be derived from endothelial cells stimulated with interleukin-6. |
HCAECs, HGECs, HGFBs, hs-CRP, IL |
| 91 |
2011 |
Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. |
sgp130, sgp130 |
| 92 |
2011 |
Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE(2) production in chondrocytes. |
COX, IL-6, M-CSF, OPG, RANKL, TRAP |
| 93 |
2011 |
Post-transcriptional regulation of IL-6 production by Zc3h12a in fibroblast-like synovial cells. |
FLS, RA, STAT3 |
| 94 |
2011 |
Radiographic bone damage in chronic gout is negatively associated with the inflammatory cytokines soluble interleukin 6 receptor and osteoprotegerin. |
IL-1ss, OPG, RANKL |
| 95 |
2011 |
SHBG, sex hormones, and inflammatory markers in older women. |
CRP |
| 96 |
2011 |
Soluble gp130 regulatess interleukin-6 in cerebrospinal fluid after subarachnoid haemorrhage. |
CSF, IL-6, SAH, sgp130 |
| 97 |
2010 |
Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis. |
AIA, IL-6, sgp130 |
| 98 |
2010 |
High molecular weight hyaluronic acid inhibits IL-6-induced MMP production from human chondrocytes by up-regulating the ERK inhibitor, MKP-1. |
ERK, HA, IL-6, MAPK, MEK, MKP-1, MMPs, STAT |
| 99 |
2010 |
IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression. |
MMPs |
| 100 |
2010 |
Inactivation of IL-6 and soluble IL-6 receptor by neutrophil derived serine proteases in cystic fibrosis. |
BALF, CF, IL-8 |
|
A Search Service for Abbreviation / Long Form
